| __timestamp | Alpine Immune Sciences, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 12122000 |
| Thursday, January 1, 2015 | 16054000 | 13380000 |
| Friday, January 1, 2016 | 23316000 | 21221000 |
| Sunday, January 1, 2017 | 10626000 | 26887000 |
| Monday, January 1, 2018 | 28970000 | 27863000 |
| Tuesday, January 1, 2019 | 35847000 | 55908000 |
| Wednesday, January 1, 2020 | 27185000 | 59392000 |
| Friday, January 1, 2021 | 58742000 | 69012000 |
| Saturday, January 1, 2022 | 70243000 | 36082000 |
| Sunday, January 1, 2023 | 80904000 | 24537000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Ligand Pharmaceuticals Incorporated have been at the forefront of this race. From 2014 to 2023, Alpine Immune Sciences has shown a remarkable increase in R&D expenses, growing by over 560%, peaking in 2023. In contrast, Ligand Pharmaceuticals saw a more modest increase of around 100% during the same period, with a peak in 2021. This divergence highlights Alpine's aggressive push towards innovation, while Ligand's spending reflects a more stable approach. The data suggests that Alpine's strategy may be paying off, as their R&D spending surpassed Ligand's by 2023. This trend underscores the dynamic nature of the biotech industry, where strategic investments in R&D can drive future growth and success.
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Ligand Pharmaceuticals Incorporated and Evotec SE